| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0097 | 1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |